Browse/search for people

Publication - Professor Mark Dillingham

    Structural basis for the inhibition of RecBCD by Gam and its synergistic antibacterial effect with quinolones

    Citation

    Wilkinson, M, Troman, L, Kamil, WNIWA, Chaban, Y, Avison, MB, Dillingham, MS & Wigley, DB, 2016, ‘Structural basis for the inhibition of RecBCD by Gam and its synergistic antibacterial effect with quinolones’. eLife, vol 5.

    Abstract

    Our previous paper (Wilkinson et al, 2016) used high-resolution cryo-electron microscopy to solve the structure of the Escherichia coli RecBCD complex, which acts in both the repair of double-stranded DNA breaks and the degradation of bacteriophage DNA. To counteract the latter activity, bacteriophage λ encodes a small protein inhibitor called Gam that binds to RecBCD and inactivates the complex. Here, we show that Gam inhibits RecBCD by competing at the DNA-binding site. The interaction surface is extensive and involves molecular mimicry of the DNA substrate. We also show that expression of Gam in E. coli or Klebsiella pneumoniae increases sensitivity to fluoroquinolones; antibacterials that kill cells by inhibiting topoisomerases and inducing double-stranded DNA breaks. Furthermore, fluoroquinolone-resistance in K. pneumoniae clinical isolates is reversed by expression of Gam. Together, our data explain the synthetic lethality observed between topoisomerase-induced DNA breaks and the RecBCD gene products, suggesting a new co-antibacterial strategy.

    Full details in the University publications repository